Gossamer Bio Inc (GOSS)
US$ 1.094.81%
Price Chart
Key Statistics
Market Cap
$ 386.41M
P/E Ratio
0.00
Revenue (TTM)
$ 124.59M
Volume
1.65M
52W High
$ 1.90
52W Low
$ 0.66
Dividend Yield
0.00%
Beta
1.85
Technicals
50-Day MA
1.2602
200-Day MA
1.0558
52 Week High
1.9
52 Week Low
0.6617
About GOSS
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary arterial hypertension (PAH) in the United States.
Employees
144
Headquarters
San Diego, CA
CEO
Mr. Faheem Hasnain
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg